By Jeannie O'Sullivan ( February 8, 2022, 3:00 PM EST) -- A lender for bankrupt generic pharmaceutical company Teligent Inc. slammed a bid by unsecured creditors for derivative standing to claw back a $10 million reserve fund, insisting the debtor didn't incur any harm by satisfying the lending agreement....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.